Prediction of the potency of mammalian cyclooxygenase inhibitors with ensemble proteochemometric modeling
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Cyclooxygenases (COX) are present in the body in two isoforms, namely: COX-1, constitutively expressed, and COX-2, induced in physiopathological conditions such as cancer or chronic inflammation. The inhibition of COX with non-steroideal anti-inflammatory drugs (NSAIDs) is the most widely used treatment for chronic inflammation despite the adverse effects associated to prolonged NSAIDs intake. Although selective COX-2 inhibition has been shown not to palliate all adverse effects (e.g. cardiotoxicity), there are still niche populations which can benefit from selective COX-2 inhibition. Thus, capitalizing on bioactivity data from both isoforms simultaneously would contribute to develop COX inhibitors with better safety profiles. We applied ensemble proteochemometric modeling (PCM) for the prediction of the potency of 3,228 distinct COX inhibitors on 11 mammalian cyclooxygenases. Ensemble PCM models ( $R_{0\ test}^{2}=0.65$ R 0 test 2 = 0.65 , and RMSE test = 0.71) outperformed models exclusively trained on compound ( $R_{0\ test}^{2}=0.17$ R 0 test 2 = 0.17 , and RMSE test = 1.09) or protein descriptors ( $R_{0\ test}^{2}=0.16$ R 0 test 2 = 0.16 and RMSE test = 1.10) on the test set. Moreover, PCM predicted COX potency for 1,086 selective and non-selective COX inhibitors with $R_{0\ test}^{2}=0.59$ R 0 test 2 = 0.59 and RMSE test = 0.76. These values are in agreement with the maximum and minimum achievable $R_{0\ test}^{2}$ R 0 test 2 and RMSE test values of approximately 0.68 for both metrics. Confidence intervals for individual predictions were calculated from the standard deviation of the predictions from the individual models composing the ensembles. Finally, two substructure analysis pipelines singled out chemical substructures implicated in both potency and selectivity in agreement with the literature.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538
A concordance correlation coefficient to evaluate reproducibility.
Lin, L. I.-K. (1989) · Biometrics · doi:10.2307/2532051 · Cited by 8,785 · cited 2×
“Abreviations: CCC Concordance Correlation Coefficient [75,76], EN Elastic Net, GBM Gradient Boosting Machine, Ind. Individual,MSModels Stacking, RF Random Forest, RMSE root mean square error in prediction, SVM Support Vector Machines. public IC50 data reported by Kalliokoski et al. [37] The mean of the distribution of…”
MethodInfluentialKuhn, M., & Johnson, K. (2013) · doi:10.1007/978-1-4614-6849-3 · Cited by 6,788 · cited 1×
“Model generation 210 Descriptors with a variance close to zero were removed 211 with the function RemoveNearZeroVarianceFeatures from 212 the R package camb using a cut-off value equal to 30/1 213 [41,49,51].”
MethodChEMBL: a large-scale bioactivity database for drug discovery
Gaulton, A., Bellis, L. J., Bento, A. P., Chambers, J., Davies, M., Hersey, A., Light, Y., McGlinchey, S., Michalovich, D., Al-Lazikani, B., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr777 · Cited by 4,382 · cited 3×
“Chemical space The initial bioactivity selection from ChEMBL 16 [36], consisted of 6,804 datapoints.”
BackgroundMethodInfluentialGolbraikh, A., & Tropsha, A. (2002) · Journal of Molecular Graphics and Modelling · doi:10.1016/s1093-3263(01)00123-1 · Cited by 3,735 · cited 3×
“[54-56], and to the RMSE values (Equation 1).”
BackgroundMethodCardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial
Bresalier, R. S., Sandler, R. S., Quan, H., Bolognese, J. A., Oxenius, B., Horgan, K., Lines, C., Riddell, R., Morton, D., Lanas, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050493 · Cited by 2,519
Shaffer, J. P. (1995) · Annual Review of Psychology · doi:10.1146/annurev.ps.46.020195.003021 · Cited by 1,960
Chemical substructures that enrich for biological activity
Klekota, J., & Roth, F. P. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn479 · Cited by 392
van Westen, G. J. P., Wegner, J. K., IJzerman, A. P., van Vlijmen, H. W. T., & Bender, A. (2011) · MedChemComm · doi:10.1039/c0md00165a · Cited by 176
Self-citationSubstrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation
Hermanson, D. J., Hartley, N. D., Gamble-George, J., Brown, N., Shonesy, B. C., Kingsley, P. J., Colbran, R. J., Reese, J., Marnett, L. J., & Patel, S. (2013) · Nature Neuroscience · doi:10.1038/nn.3480 · Cited by 126 · cited 1×
“In addition, selective COX-2 inhibitors continue to be the common treatment for chronic inflammatory and pain disorders [3,11], and NSAIDs are known to reduce the risk of (among others) [12-15]: colon cancer [16-19], Alzheimer’s disease, and platelet aggregation [5,20].”
Background
Cited by
CB-Dock: a web server for cavity detection-guided protein–ligand blind docking
Liu, Y., Grimm, M., Dai, W.-T., Hou, M.-C., Xiao, Z.-X., & Cao, Y. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-019-0228-6 · Cited by 881
Krivák, R., & Hoksza, D. (2018) · Journal of Cheminformatics · doi:10.1186/s13321-018-0285-8 · Cited by 583
Potential Impact of the Multi-Target Drug Approach in the Treatment of Some Complex Diseases
Makhoba, X. H., Viegas Jr., C., Mosa, R. A., Viegas, F. P., & Pooe, O. J. (2020) · Drug Design, Development and Therapy · doi:10.2147/dddt.s257494 · Cited by 321
Data-driven materials research enabled by natural language processing and information extraction
Olivetti, E. A., Cole, J. M., Kim, E., Kononova, O., Ceder, G., Han, T. Y.-J., & Hiszpanski, A. M. (2020) · Applied Physics Reviews · doi:10.1063/5.0021106 · Cited by 302
Machine and deep learning approaches for cancer drug repurposing
Issa, N. T., Stathias, V., Schürer, S., & Dakshanamurthy, S. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.12.011 · Cited by 274
Metadata
- Authors
- Cortes-Ciriano, I., Murrell, D. S., van Westen, G. J., Bender, A., & Malliavin, T. E.
- Venue
- Journal of Cheminformatics
- Published
- 2015-01-16
- Volume
- 7
- Issue
- 1
- Pages
- 1-1
- ISSN
- 1758-2946 (ISSN-L)
- OpenAlex
- W2168990503
- Cited by
- 118
- References
- 11
- FWCI
- 12.98
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prediction of the potency of mammalian cyclooxygenase inhibitors with ensemble proteochemometric modeling. https://app.cochat.ai/papers/10.1186/s13321-014-0049-z
- The paper
- Cortes-Ciriano, I., Murrell, D. S., van Westen, G. J., Bender, A., & Malliavin, T. E. (2015). Prediction of the potency of mammalian cyclooxygenase inhibitors with ensemble proteochemometric modeling. Journal of Cheminformatics. https://doi.org/10.1186/s13321-014-0049-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.